Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report (Q36995645)

17 August 2017

Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report (English)

1 reference

von Hippel-Lindau disease

17 August 2017

1 reference

1 reference

6

William Kaelin

1 reference

17 August 2017

Lisa R Rogers

1

1 reference

17 August 2017

Patricia LoRusso

2

1 reference

17 August 2017

Paul Nadler

3

1 reference

17 August 2017

Ghaus Malik

4

1 reference

17 August 2017

Anthony Shields

5

1 reference

17 August 2017

language of work or name

1 reference

4 June 2010

1 reference

Journal of Neuro-Oncology

17 August 2017

1 reference

17 August 2017

101

1 reference

17 August 2017

2

1 reference

17 August 2017

307-310

1 reference

Stabilization of a progressive hemangioblastoma under treatment with thalidomide

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous system

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Gamma knife surgery for multiple hemangioblastomas

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Antiangiogenic therapy for von Hippel-Lindau disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Leptomeningeal Hemangioblastomatosis in a Case of von Hippel-Lindau Disease: Case Report

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Interferon alpha-2a therapy in 18 hemangioblastomas.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3705918

Expression of growth factors and growth factor receptors in capillary hemangioblastoma

4 September 2018

1 reference

12 December 2020

Spinal leptomeningeal hemangioblastomatosis in von Hippel-Lindau disease: magnetic resonance and pathological findings

1 reference

12 December 2020

Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416

1 reference

12 December 2020

Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer

1 reference

12 December 2020

The role of stereotactic radiosurgery for intracranial hemangioblastomas

1 reference

12 December 2020

Spinal deformity: a new classification derived from neutral upright spinal alignment measurements in asymptomatic juvenile, adolescent, adult, and geriatric individuals

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/S11060-010-0244-3

Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1007/S11060-010-0244-3

Identifiers

DOI

10.1007/S11060-010-0244-3

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

20524042

1 reference